SI1100469T1 - - Google Patents

Info

Publication number
SI1100469T1
SI1100469T1 SI9930784T SI9930784T SI1100469T1 SI 1100469 T1 SI1100469 T1 SI 1100469T1 SI 9930784 T SI9930784 T SI 9930784T SI 9930784 T SI9930784 T SI 9930784T SI 1100469 T1 SI1100469 T1 SI 1100469T1
Authority
SI
Slovenia
Application number
SI9930784T
Inventor
Toshihiro Shimizu
Masae Sugaya
Yoshinori Nakano
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=16632688&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1100469(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of SI1100469T1 publication Critical patent/SI1100469T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI9930784T 1998-07-28 1999-07-27 SI1100469T1 (cs)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP21304998 1998-07-28
PCT/JP1999/004015 WO2000006126A1 (en) 1998-07-28 1999-07-27 Rapidly disintegrable solid preparation

Publications (1)

Publication Number Publication Date
SI1100469T1 true SI1100469T1 (cs) 2005-08-31

Family

ID=16632688

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9930784T SI1100469T1 (cs) 1998-07-28 1999-07-27

Country Status (19)

Country Link
US (4) US7399485B1 (cs)
EP (2) EP1561458B1 (cs)
JP (3) JP3404648B2 (cs)
KR (1) KR100536783B1 (cs)
CN (1) CN1149077C (cs)
AR (2) AR019935A1 (cs)
AT (2) ATE291418T1 (cs)
AU (1) AU4802099A (cs)
CA (3) CA2581111A1 (cs)
CY (1) CY1110988T1 (cs)
DE (2) DE69924381T2 (cs)
DK (2) DK1561458T3 (cs)
ES (2) ES2237121T3 (cs)
MY (2) MY151098A (cs)
PT (2) PT1561458E (cs)
SI (1) SI1100469T1 (cs)
TW (2) TW585786B (cs)
WO (1) WO2000006126A1 (cs)
ZA (1) ZA200100285B (cs)

Families Citing this family (137)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2587022A1 (en) 1998-05-18 1999-11-25 Takeda Pharmaceutical Company Limited Orally disintegrable tablets
CA2581111A1 (en) 1998-07-28 2000-02-10 Takeda Pharmaceutical Company Limited Rapidly disintegrable solid preparation
AU5248900A (en) 1999-06-18 2001-01-09 Takeda Chemical Industries Ltd. Quickly disintegrating solid preparations
JP2001058944A (ja) * 1999-06-18 2001-03-06 Takeda Chem Ind Ltd 速崩壊性固形製剤
DE60110666T2 (de) 2000-03-17 2006-02-02 Shin-Etsu Chemical Co., Ltd. Feste Zubereitung enthaltend niedersubstituierte Hydroxypropylcellulose und Herstellungsverfahren
CA2403594A1 (en) * 2000-03-27 2002-09-18 Kyowa Hakko Kogyo Co., Ltd. Granules having good taking property
JP4802436B2 (ja) * 2000-04-12 2011-10-26 Ｍｓｄ株式会社 口腔内崩壊型組成物及び口腔内崩壊型製剤
US6316029B1 (en) * 2000-05-18 2001-11-13 Flak Pharma International, Ltd. Rapidly disintegrating solid oral dosage form
JP4840549B2 (ja) * 2000-11-20 2011-12-21 トーアエイヨー株式会社 安定な血管拡張剤及びその製造方法
SI1341528T1 (sl) * 2000-12-07 2012-05-31 Nycomed Gmbh Hitro razpadljiva tableta ki obsega kislinsko labilno aktivno sestavino
US20030224047A1 (en) * 2001-02-15 2003-12-04 Franz G. Andrew Levothyroxine compositions and methods
WO2002064119A1 (en) * 2001-02-15 2002-08-22 Tanabe Seiyaku Co., Ltd. Tablets quickly disintegrated in oral cavity
JP2004525109A (ja) 2001-02-15 2004-08-19 キング・ファーマシューティカルズ・インコーポレイティッド 安定化された甲状腺ホルモン医薬組成物、及びその製法
WO2002092058A1 (fr) * 2001-05-15 2002-11-21 Takeda Chemical Industries, Ltd. Preparation solide se desintegrant rapidement
DK1405621T3 (da) * 2001-06-20 2011-07-18 Takeda Pharmaceutical Fremgangsmåde til fremstilling af tablet
WO2003007968A1 (en) * 2001-07-17 2003-01-30 Sun Pharmaceutical Industries Ltd. A cardiotonic composition
US7101569B2 (en) 2001-08-14 2006-09-05 Franz G Andrew Methods of administering levothyroxine pharmaceutical compositions
EP1430888A1 (en) * 2001-09-28 2004-06-23 Sanwa Kagaku Kenkyusho Co., Ltd. Press-coated molded article undergoing quick disintegration
DK1459737T3 (da) 2001-10-17 2013-01-02 Takeda Pharmaceutical Granulat indeholdende syreustabilt kemisk middel i stor mængde
US20040047904A1 (en) * 2001-11-13 2004-03-11 Motohiro Ohta Amino acid-containing tablets quickly disintegrating in the oral cavity and process for producing the same
JP2003238393A (ja) * 2002-02-15 2003-08-27 Otsuka Pharmaceut Co Ltd 施錠性が改善された錠剤及びその製造方法
DE10209982A1 (de) * 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Oral zu applizierende Darreichungsform für schwerlösliche basische Wirkstoffe
US20030181488A1 (en) 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
CO5400144A1 (es) * 2002-03-11 2004-05-31 Novartis Ag Compuestos organicos
EP2283864A1 (en) * 2002-07-16 2011-02-16 Elan Pharma International Ltd. Liquid dosage compositions fo stable nanoparticulate active agents
US20040018990A1 (en) * 2002-07-25 2004-01-29 Harvey Rosner Treatment of obesity
MXPA05003357A (es) * 2002-10-02 2005-06-22 Meiji Seika Kaisha Composicion medicinal antibacteriana de capacidad de absorcion oral mejorada.
UA80991C2 (en) * 2002-10-07 2007-11-26 Solid preparation containing an insulin resistance improving drug and an active ingredient useful as a remedy for diabetes
JP4493970B2 (ja) * 2002-10-16 2010-06-30 武田薬品工業株式会社 持続性製剤
ES2534713T3 (es) 2002-10-16 2015-04-27 Takeda Pharmaceutical Company Limited Preparaciones sólidas estables
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
US20050220870A1 (en) * 2003-02-20 2005-10-06 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
EP1759692A3 (en) * 2003-03-10 2007-09-12 Novartis AG Taste-masked solid veterinary compositions
US8449911B2 (en) 2003-03-12 2013-05-28 Takeda Pharmaceutical Company Limited Drug composition having active ingredient adhered at high concentration to spherical core
US8263126B2 (en) 2003-06-06 2012-09-11 Ethypharm Orally-dispersible multilayer tablet
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20050037070A1 (en) * 2003-07-18 2005-02-17 Santarus, Inc. Pharmaceutical formulatins useful for inhibiting acid secretion and methods for making and using them
US7838029B1 (en) 2003-07-31 2010-11-23 Watson Laboratories, Inc. Mirtazapine solid dosage forms
JP4601271B2 (ja) * 2003-08-01 2010-12-22 大洋薬品工業株式会社 圧縮成形製剤およびその製造方法
KR100882156B1 (ko) * 2003-08-08 2009-02-06 아지노모토 가부시키가이샤 나테글리니드 함유 제제
JP4780522B2 (ja) 2003-11-14 2011-09-28 味の素株式会社 フェニルアラニン誘導体の固体分散体または固体分散体医薬製剤
JP4767492B2 (ja) * 2003-12-25 2011-09-07 ライオン株式会社 高分子被覆粒子の製造方法、高分子被覆粒子、並びにこれを用いた圧縮成形品
US7670624B2 (en) 2004-01-29 2010-03-02 Astella Pharma Inc. Gastrointestinal-specific multiple drug release system
CA2554271A1 (en) * 2004-02-10 2005-08-25 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent
WO2005084648A1 (en) * 2004-02-27 2005-09-15 Ranbaxy Laboratories Limited Pharmaceutical compositions comprising candesartan cilexetil
WO2005117870A2 (en) * 2004-04-16 2005-12-15 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and prokinetic agent
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
ATE493973T1 (de) 2004-06-04 2011-01-15 Teva Pharma Irbesartan enthaltende pharmazeutische zusammensetzung
AU2005291299A1 (en) * 2004-10-05 2006-04-13 Altana Pharma Ag Oral pharmaceutical preparation for proton pump antagonists
CN101068546A (zh) * 2004-10-06 2007-11-07 卫材R&D管理有限公司 医药组合物及其制造方法以及医药组合物中的二氢吡啶类化合物的稳定化方法
WO2006076097A2 (en) * 2004-12-07 2006-07-20 Nektar Therapeutics Stable non-crystalline formulation comprising losartan
ATE518526T1 (de) * 2005-01-26 2011-08-15 Lek Pharmaceuticals Neue pharmazeutische zusammensetzung mit candesartan-cilexetil als lipophile kristalline substanz
AU2006233640B8 (en) * 2005-04-15 2011-01-06 Keme Food Engineering Ag Instant product
WO2006118210A1 (ja) * 2005-04-28 2006-11-09 Eisai R & D Management Co., Ltd. ジヒドロピリジン系化合物の分解を防止する方法
US20070082048A1 (en) * 2005-06-08 2007-04-12 Ronald Warner Sleep aid formulations
PL1897558T3 (pl) * 2005-06-09 2014-01-31 Norgine Bv Stały preparat 2-heksadecyloksy-6-metylo-4H-3,1-benzoksazyn-4-onu
KR100730393B1 (ko) * 2005-06-10 2007-06-20 한국콜마 주식회사 이부프로펜 및 아르기닌을 함유하는 약학 조성물의제조방법
JP4739340B2 (ja) * 2005-07-22 2011-08-03 田辺三菱製薬株式会社 口腔内速崩壊性錠
EP1920786B8 (en) * 2005-07-25 2012-02-22 Otsuka Pharmaceutical Co., Ltd. Oral preparation for measuring pyrimidine metabolic capacity
EP1915137B8 (de) * 2005-08-10 2013-09-11 ADD Advanced Drug Delivery Technologies, Ltd. Orales präparat mit kontrollierter freisetzung
JP2009511481A (ja) * 2005-10-06 2009-03-19 オースペックス・ファーマシューティカルズ・インコーポレイテッド 増強された治療特性を持つ、胃Ｈ＋，Ｋ＋−ＡＴＰａｓｅの重水素化阻害剤
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
PE20070698A1 (es) 2005-11-14 2007-08-17 Teijin Pharma Ltd Comprimido de disgregacion rapida intraoral que contiene hidrocloruro de ambroxol
DE202006020168U1 (de) * 2005-12-21 2008-07-17 Basf Se Pharmazeutische Formulierung für die Herstellung von schnell zerfallenden Tabletten
NZ569071A (en) 2005-12-22 2011-01-28 Takeda Pharmaceutical Solid preparation containing an insulin sensitizer
WO2007074909A1 (ja) 2005-12-28 2007-07-05 Takeda Pharmaceutical Company Limited 放出制御固形製剤
EP1967211A4 (en) 2005-12-28 2009-12-30 Takeda Pharmaceutical PROCESS FOR PRODUCING SOLID PREPARATION DISINTEGRATING IN ORAL CAVITY
JP3884056B1 (ja) * 2006-01-27 2007-02-21 秋山錠剤株式会社 口腔内速崩錠の製造方法
DE102006006588A1 (de) * 2006-02-13 2007-08-16 Ratiopharm Gmbh Schnell freisetzende Irbesartan-haltige pharmazeutische Zusammensetzung
AU2007232098A1 (en) * 2006-03-31 2007-10-11 Rubicon Research Private Limited Directly compressible composite for orally disintegrating tablets
SG170823A1 (en) * 2006-04-13 2011-05-30 Otsuka Pharma Co Ltd Test agent for diagnosing dyspepsia
JP5276991B2 (ja) * 2006-04-27 2013-08-28 武田薬品工業株式会社 固形製剤
TWI494134B (zh) * 2006-06-20 2015-08-01 Siegfried Generics Int Ag 含有坎地沙坦酯的組成物、錠劑和顆粒及該錠劑的製造方法
US20080014228A1 (en) * 2006-07-14 2008-01-17 Olivia Darmuzey Solid form
AU2007280471B2 (en) 2006-08-04 2012-10-18 Ethypharm Multilayer orally disintegrating tablet
WO2008015220A1 (en) * 2006-08-04 2008-02-07 Ethypharm Granule and orally disintegrating tablet comprising oxycodone
US20080031944A1 (en) * 2006-08-04 2008-02-07 Cima Labs Inc. Stabilization of lorazepam
BG109687A (bg) * 2006-09-26 2008-03-31 Иван ХРИСТОВ Антиастматично лекарствено средство
WO2008068727A2 (en) * 2006-12-06 2008-06-12 Ranbaxy Laboratories Limited Pharmaceutical composition comprising candesartan cilexetil
EP2101738A2 (en) * 2006-12-21 2009-09-23 Mallinckrodt Inc. Composition of and method for preparing orally disintegrating tablets
TWI488658B (zh) * 2006-12-26 2015-06-21 Daiichi Sankyo Co Ltd 溶出性之改善方法
JP5366558B2 (ja) * 2006-12-28 2013-12-11 武田薬品工業株式会社 口腔内崩壊性固形製剤
WO2008094877A2 (en) * 2007-01-30 2008-08-07 Drugtech Corporation Compositions for oral delivery of pharmaceuticals
JP3967767B1 (ja) * 2007-02-08 2007-08-29 秋山錠剤株式会社 口腔内速崩錠の製造方法
CN101646461A (zh) 2007-03-13 2010-02-10 大日本住友制药株式会社 口腔崩解片
US8679541B2 (en) 2007-03-14 2014-03-25 Particle Dynamics International, Llc Spatial arrangement of particles in a drinking device for oral delivery of pharmaceuticals
US20080311162A1 (en) * 2007-05-16 2008-12-18 Olivia Darmuzey Solid form
EP2164460B1 (de) * 2007-06-06 2017-08-09 Basf Se Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten
WO2008148734A1 (de) * 2007-06-06 2008-12-11 Basf Se Pharmazeutische formulierung für die herstellung von kau- und lutsch-tabletten
CA2688389A1 (en) * 2007-06-06 2008-12-11 Basf Se Pharmaceutical formulation for the production of rapidly disintegrating tablets
EP2164462B1 (de) * 2007-06-06 2017-05-31 Basf Se Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten
WO2009022670A1 (ja) * 2007-08-10 2009-02-19 Takeda Pharmaceutical Company Limited 速崩壊性錠剤
US8323695B2 (en) * 2007-08-13 2012-12-04 Mcneil-Ppc, Inc. Method for stabilizing phenylephrine
WO2009041651A1 (ja) * 2007-09-27 2009-04-02 Mitsubishi Tanabe Pharma Corporation 速崩壊性固形製剤
DE102007052070A1 (de) 2007-10-30 2009-05-07 Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg Candesartancilexetil
ITMI20072226A1 (it) * 2007-11-23 2009-05-24 Chiesi Farma Spa Un metodo per determinare la purezza polimorfica di manidipina dicloridrato
BRPI0820997A2 (pt) * 2007-12-10 2014-12-23 Eurand Inc Comprimidos de desintegração oral compreendendo difenidramina.
JP5352474B2 (ja) * 2007-12-28 2013-11-27 沢井製薬株式会社 口腔内崩壊錠およびその製造方法
PL2254591T3 (pl) * 2008-02-08 2018-01-31 Prothera Inc Inhibicja i leczenie biofilmów żołądkowo-jelitowych
CN102026627B (zh) 2008-03-11 2016-10-26 武田药品工业株式会社 口腔崩解固体制剂
EP3031451B1 (en) 2009-01-26 2018-03-07 Shin-Etsu Chemical Co., Ltd Wet granulation tableting method using aqueous dispersion of low-substituted hydroxypropyl cellulose
US10653235B2 (en) * 2009-07-08 2020-05-19 Wayne R Solan Toothpaste droplets
GB201003731D0 (en) 2010-03-05 2010-04-21 Univ Strathclyde Immediate/delayed drug delivery
GB201003734D0 (en) * 2010-03-05 2010-04-21 Univ Strathclyde Delayed prolonged drug delivery
JP5031054B2 (ja) 2010-03-18 2012-09-19 信越化学工業株式会社 低置換度ヒドロキシプロピルセルロース及びこれを含む固形製剤
WO2011150098A1 (en) * 2010-05-25 2011-12-01 David Kossor Compositions and methods for reduction of mercury toxicity
WO2012014052A2 (en) * 2010-07-30 2012-02-02 Micro Labs Limited Novel coated extended release pharmaceutical compositions containing paliperidone
CN102379854A (zh) * 2010-08-31 2012-03-21 扬子江药业集团北京海燕药业有限公司 盐酸马尼地平口服速释制剂及其制备方法
US8623978B2 (en) 2010-11-23 2014-01-07 Basf Se Process for the preparation of low-peroxide crosslinked vinyllactam polymer
JP2011046750A (ja) * 2010-12-09 2011-03-10 Mitsubishi Tanabe Pharma Corp 口腔内速崩壊性錠
KR20140007364A (ko) 2010-12-27 2014-01-17 다케다 야쿠힌 고교 가부시키가이샤 구강내 붕괴정
JP2012162467A (ja) * 2011-02-04 2012-08-30 Sawai Pharmaceutical Co Ltd カンデサルタンシレキセチル含有造粒物の製造方法及びカンデサルタンシレキセチル含有錠剤の製造方法
DE112012001679B4 (de) 2011-04-12 2023-05-04 Basf Se Abgeschlossene, schutzgasgefüllte Verpackungsform, enthaltend ein oxidationsempfindliches, peroxidarmes Polymer, dessen Verwendung und Verfahren zur Stabilisierung von oxidationsempfindlichen Polymeren gegen Peroxidbildung
EP2511331A1 (de) 2011-04-12 2012-10-17 Basf Se Peroxidarmes Polymer enthaltend Phosphorverbindung
DE202011005055U1 (de) 2011-04-12 2011-09-12 Basf Se Peroxidarmes Polymer enthaltend Phosphorverbindung
US9023931B2 (en) 2011-04-12 2015-05-05 Basf Se Oxidation-sensitive, low-peroxide polymer comprising at least one inorganic phosphorus compound
WO2013081563A2 (en) 2011-10-24 2013-06-06 Mahmut Bilgic Stable tablet formulations
WO2013081177A1 (en) 2011-11-30 2013-06-06 Takeda Pharmaceutical Company Limited Dry coated tablet
CN104737016B (zh) 2012-08-20 2017-09-29 大塚制药株式会社 测定糖代谢能力的方法及用于该方法的组合物
WO2014119667A1 (ja) * 2013-01-30 2014-08-07 沢井製薬株式会社 カンデサルタンシレキセチル含有医薬組成物
US9850512B2 (en) 2013-03-15 2017-12-26 The Research Foundation For The State University Of New York Hydrolysis of cellulosic fines in primary clarified sludge of paper mills and the addition of a surfactant to increase the yield
JP6305392B2 (ja) 2013-03-15 2018-04-04 大塚製薬株式会社 脂肪酸燃焼によるインスリン抵抗性の測定方法、並びにそれに使用する組成物
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
US10004691B2 (en) 2013-05-21 2018-06-26 Takeda Pharmaceuticals Company Limited Orally disintegrable tablet
JP6238921B2 (ja) * 2014-02-17 2017-11-29 大原薬品工業株式会社 イルベサルタンを含有する錠剤
US9951363B2 (en) 2014-03-14 2018-04-24 The Research Foundation for the State University of New York College of Environmental Science and Forestry Enzymatic hydrolysis of old corrugated cardboard (OCC) fines from recycled linerboard mill waste rejects
KR102467968B1 (ko) * 2014-10-08 2022-11-16 신세틱 바이오로직스, 인코퍼레이티드 베타-락타마제 제형 및 이의 용도
JP6340325B2 (ja) * 2014-12-29 2018-06-06 沢井製薬株式会社 ナフトピジル含有口腔内崩壊錠
US9925138B2 (en) 2015-01-20 2018-03-27 Handa Pharmaceuticals, Llc Stable solid fingolimod dosage forms
US9744135B2 (en) 2015-02-27 2017-08-29 Deseret Laboratories, Inc. Fast disintegrating compositions and tablets thereof
WO2016174664A1 (en) 2015-04-29 2016-11-03 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
JP7198575B2 (ja) * 2017-07-11 2023-01-04 キョーリンリメディオ株式会社 メマンチン塩酸塩含有口腔内崩壊錠
FR3099881B1 (fr) 2019-08-13 2022-08-26 Ethypharm Sa Comprimé orodispersible d’opioide à faible dosage et son procédé de préparation.
CN111012755A (zh) * 2020-01-09 2020-04-17 仁和堂药业有限公司 维生素b6片的制备工艺
JP7511596B2 (ja) * 2021-03-10 2024-07-05 日本ジェネリック株式会社 リバーロキサバン含有錠剤

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
JPS5411226A (en) 1977-06-24 1979-01-27 Shin Etsu Chem Co Ltd Disintegratable granule
SE8404808L (sv) 1983-10-03 1985-04-04 Avner Rotman Mikrokapslat lekemedel i sot matris
US4749575A (en) 1983-10-03 1988-06-07 Bio-Dar Ltd. Microencapsulated medicament in sweet matrix
US4612345A (en) * 1985-02-28 1986-09-16 The Dow Chemical Company Hydroxypropyl methyl cellulose ethers useful as suspending agents for suspension polymerization of vinyl chloride
GB8518301D0 (en) * 1985-07-19 1985-08-29 Fujisawa Pharmaceutical Co Hydrodynamically explosive systems
SE450087B (sv) 1985-10-11 1987-06-09 Haessle Ab Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial
CA1327010C (en) 1986-02-13 1994-02-15 Tadashi Makino Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production
US5433959A (en) * 1986-02-13 1995-07-18 Takeda Chemical Industries, Ltd. Stabilized pharmaceutical composition
US5026560A (en) * 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US5030447A (en) 1988-03-31 1991-07-09 E. R. Squibb & Sons, Inc. Pharmaceutical compositions having good stability
JPH0720858B2 (ja) 1988-04-19 1995-03-08 三菱化学株式会社 被覆固形薬剤
JPH0723304B2 (ja) 1988-04-19 1995-03-15 三菱化学株式会社 薬剤成分固定化組成物
US4910023A (en) 1988-06-09 1990-03-20 Warner-Lambert Company Drug in combination with flavor masking agent and method for making same
JPH0819003B2 (ja) * 1988-09-27 1996-02-28 武田薬品工業株式会社 有核顆粒およびその製造法
NZ230763A (en) * 1988-09-27 1991-10-25 Takeda Chemical Industries Ltd Production of granules having a core by spraying the cores with a dispersion of hydroxypropylcellulose, optionally incorporating an active ingredient
GB8824392D0 (en) 1988-10-18 1988-11-23 Ciba Geigy Ag Dispersible formulation
IT1238072B (it) 1990-01-19 1993-07-03 Sclavo Spa Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina
EP0452862B1 (en) 1990-04-18 1995-07-19 Asahi Kasei Kogyo Kabushiki Kaisha Spherical seed cores, spherical granules and process for production thereof
JPH0466538A (ja) 1990-07-04 1992-03-02 Suntory Ltd 抗潰瘍剤
US5316772A (en) 1990-12-19 1994-05-31 Solvay & Cie, S.A. (Societe Anonyme) Bilayered oral pharmaceutical composition with pH dependent release
JP2820829B2 (ja) 1991-03-07 1998-11-05 武田薬品工業株式会社 有核散剤およびその製造方法
US5464632C1 (en) 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
JP2682353B2 (ja) * 1991-11-20 1997-11-26 武田薬品工業株式会社 経口用医薬組成物およびその製造法
US5200194A (en) * 1991-12-18 1993-04-06 Alza Corporation Oral osmotic device
EP0553777B1 (en) * 1992-01-29 2002-04-24 Takeda Chemical Industries, Ltd. Fast dissolving tablet and its production
JPH05310558A (ja) 1992-05-07 1993-11-22 Lion Corp 固形製剤組成物
JP3059004B2 (ja) 1992-09-18 2000-07-04 ダイセル化学工業株式会社 アルカリ水溶液に対する溶解性の高い低置換度ヒドロキシプロピルセルロース及びその製造法
JP2647338B2 (ja) * 1993-02-10 1997-08-27 武田薬品工業株式会社 素錠およびその製造方法
JPH06305962A (ja) 1993-04-21 1994-11-01 Taisho Pharmaceut Co Ltd アトピー性皮膚炎治療剤
JP3502951B2 (ja) 1993-07-06 2004-03-02 大正製薬株式会社 高脂血症治療剤
IL110376A (en) 1993-08-02 1998-08-16 Bristol Myers Squibb Co Pharmaceutical compositions containing ifetroban salts and methods for the preparation thereof
WO1995010264A1 (en) 1993-10-12 1995-04-20 Tokyo Tanabe Company Limited Tablet containing enteric granules
US5549911A (en) * 1994-01-14 1996-08-27 Laboratoires Des Produits Ethiques Ethypharm Galenic form of 5-nitromidazole derivatives which is effective for the treatment of parasitoses and infections of the entire gastrointestinal tract
PH31467A (en) * 1994-01-31 1998-11-03 Yamanouchi Pharma Co Ltd Intrabucally dissolving compressed mouldings and production process thereof.
US5380234A (en) * 1994-05-25 1995-01-10 Ledford; Kevin D. Inflatable and deflatable combatant action toy
SE9402431D0 (sv) 1994-07-08 1994-07-08 Astra Ab New tablet formulation
JPH0827033A (ja) 1994-07-14 1996-01-30 Nikken Chem Co Ltd エリスリトール含有固形剤
SE9500422D0 (sv) 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
US20010003751A1 (en) * 1995-02-22 2001-06-14 Terashita Zen-Ichi Pharmaceutical composition for treating transient ischemic attack
SE9501881D0 (sv) 1995-05-19 1995-05-19 Astra Ab New pharmacological use of AII-receptor antagonists
JPH08310969A (ja) 1995-05-22 1996-11-26 Lion Corp 固形薬品組成物及びその製造方法
US5658583A (en) 1995-07-28 1997-08-19 Zhang; Jie Apparatus and methods for improved noninvasive dermal administration of pharmaceuticals
JPH0948726A (ja) 1995-08-07 1997-02-18 Tanabe Seiyaku Co Ltd 口腔内速崩壊性製剤およびその製法
JPH0971523A (ja) 1995-09-07 1997-03-18 Riyuukakusan:Kk 口腔内で崩壊性の速い錠剤
US5824339A (en) 1995-09-08 1998-10-20 Takeda Chemical Industries, Ltd Effervescent composition and its production
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
SE9600071D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
SE9600072D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients II
SE9600070D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
SE512835C2 (sv) 1996-01-08 2000-05-22 Astrazeneca Ab Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare
US5840332A (en) 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
ES2173420T3 (es) * 1996-02-29 2002-10-16 Fujisawa Pharmaceutical Co Comprimidos que contienen un antibiotico de beta-lactamico y procedimiento para su produccion.
EP0799616A1 (en) 1996-04-01 1997-10-08 Takeda Chemical Industries, Ltd. Oral composition comprising a fumagillol derivative
US5795909A (en) * 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
CA2258159C (en) 1996-06-14 2006-03-21 Kyowa Hakko Kogyo Co., Ltd. Intraorally rapidly disintegrable tablet
CA2260038A1 (en) * 1996-07-12 1998-01-22 Daiichi Pharmaceutical Co., Ltd. Quickly disintegratable compression-molded materials and process for producing the same
US5958453A (en) * 1996-10-31 1999-09-28 Takeda Chemical Industries, Ltd. Solid pharmaceutical preparation with improved buccal disintegrability and/or dissolubility
ES2257772T3 (es) * 1996-11-15 2006-08-01 Ajinomoto Co., Inc. Preparacion de nateglinida en comprimidos.
US6024981A (en) * 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
TW580397B (en) * 1997-05-27 2004-03-21 Takeda Chemical Industries Ltd Solid preparation
JP3718341B2 (ja) * 1998-05-12 2005-11-24 信越化学工業株式会社 低置換度ヒドロキシプロピルセルロースとその製造方法
CA2587022A1 (en) * 1998-05-18 1999-11-25 Takeda Pharmaceutical Company Limited Orally disintegrable tablets
CA2581111A1 (en) 1998-07-28 2000-02-10 Takeda Pharmaceutical Company Limited Rapidly disintegrable solid preparation
US6531152B1 (en) 1998-09-30 2003-03-11 Dexcel Pharma Technologies Ltd. Immediate release gastrointestinal drug delivery system

Also Published As

Publication number Publication date
TW585786B (en) 2004-05-01
JP2000344660A (ja) 2000-12-12
AR019935A1 (es) 2002-03-27
US7399485B1 (en) 2008-07-15
TW200302742A (en) 2003-08-16
AU4802099A (en) 2000-02-21
CN1310613A (zh) 2001-08-29
WO2000006126A1 (en) 2000-02-10
HK1035501A1 (en) 2001-11-30
ZA200100285B (en) 2002-01-10
US20070254031A1 (en) 2007-11-01
JP2010132709A (ja) 2010-06-17
EP1100469B1 (en) 2005-03-23
CY1110988T1 (el) 2015-06-11
AR080436A2 (es) 2012-04-11
EP1100469A1 (en) 2001-05-23
PT1561458E (pt) 2010-10-11
CN1149077C (zh) 2004-05-12
DE69924381T2 (de) 2006-04-20
EP1561458A1 (en) 2005-08-10
ATE481090T1 (de) 2010-10-15
MY151098A (en) 2014-04-15
CA2581111A1 (en) 2000-02-10
PT1100469E (pt) 2005-06-30
DK1561458T3 (da) 2010-10-25
CA2338792A1 (en) 2000-02-10
JP3404648B2 (ja) 2003-05-12
US20010010825A1 (en) 2001-08-02
JP2000103731A (ja) 2000-04-11
DE69942777D1 (de) 2010-10-28
CA2525555A1 (en) 2000-02-10
KR20010071026A (ko) 2001-07-28
DK1100469T3 (da) 2005-04-18
ES2237121T3 (es) 2005-07-16
ES2347968T3 (es) 2010-11-26
TWI257311B (en) 2006-07-01
HK1077742A1 (en) 2006-02-24
MY154010A (en) 2015-04-30
CA2338792C (en) 2006-01-17
ATE291418T1 (de) 2005-04-15
JP4573397B2 (ja) 2010-11-04
KR100536783B1 (ko) 2005-12-14
US20060182802A1 (en) 2006-08-17
EP1561458B1 (en) 2010-09-15
US7070805B2 (en) 2006-07-04
DE69924381D1 (de) 2005-04-28

Similar Documents

Publication Publication Date Title
BE2014C048I2 (cs)
JP2001514453A5 (cs)
BRPI9917862A2 (cs)
BE2011C024I2 (cs)
BRPI9816295A2 (cs)
BRPI9917863A2 (cs)
CN3073190S (cs)
CN3076421S (cs)
CN3072688S (cs)
CN3078569S (cs)
CN3072761S (cs)
CN3072873S (cs)
CN3078087S (cs)
CN3073425S (cs)
CN3073771S (cs)
CN3074052S (cs)
CN3074053S (cs)
CN3074054S (cs)
CN3074158S (cs)
CN3074692S (cs)
CN3074906S (cs)
CN3074964S (cs)
CN3074993S (cs)
CN3075068S (cs)
CN3075297S (cs)